Acumen Pharmaceuticals, Inc. (ABOS) Operating income 2020–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual operating income history from SEC filings — each fiscal year as reported.
-$123.8MFY2025 · since FY2020: -$7.9M → -$123.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.8M | -8.6% |
| FY2024 | -$114.0M | -86.5% |
| FY2023 | -$61.1M | -35.2% |
| FY2022 | -$45.2M | -131.0% |
| FY2021 | -$19.6M | -147.5% |
| FY2020 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABOS financial trends
ABOS RevenueABOS Net incomeABOS Net marginABOS Gross profitABOS Gross marginABOS Operating marginABOS Operating cash flowABOS Free cash flowABOS Capital expendituresABOS Return on equityABOS Stock buybacksABOS Dividends paidABOS Total assetsABOS Total liabilitiesABOS Shareholders’ equityABOS overview →